A Case of Retinal Hemorrhage Following a Dexamethasone Intravitreal Implant
Journal of the Korean Ophthalmological Society
;
: 93-97, 2017.
Article
Dans Coréen
| WPRIM
| ID: wpr-56576
ABSTRACT
PURPOSE:
To report a case of retinal hemorrhage after a dexamethasone (Ozurdex®, Allergan, Irvine, CA, USA) intravitreal implant injection in macular edema (ME) secondary to central retinal vein occlusion (CRVO). CASESUMMARY:
A 60-year-old woman visited our hospital for ME secondary to CRVO in the right eye. Intravitreal bevacizumab injection and vitrectomy was conducted three times, but ME did not improve. Then, dexamethasone intravitreal implant was injected without any problems. Right after the dexamethasone intravitreal implant injection, retinal hemorrhage (2 disc diopter size) was observed in the infero-temporal area on fundus examination. Retinal hemorrhage completely disappeared 1 month after injection without other treatment.CONCLUSIONS:
A case of dexamethasone intravitreal implant associated with retinal hemorrhage has not been previously reported in Korea. Althrough retinal hemorrhage was observed, it resolved spontaneously without treatment.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Veine centrale de la rétine
/
Rétinal
/
Vitrectomie
/
Dexaméthasone
/
Hémorragie de la rétine
/
Oedème maculaire
/
Bévacizumab
/
Corée
Limites du sujet:
Femelle
/
Humains
Pays comme sujet:
Asie
langue:
Coréen
Texte intégral:
Journal of the Korean Ophthalmological Society
Année:
2017
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS